It is very uncertain whether antidepressants changes dropouts due to any cause (acceptability) compared with placebo (very low certainty).
It is very uncertain whether antidepressants changes treatment acceptability ‐ dropouts (early phase, < 5 weeks) compared with treatment (very low certainty).
It is very uncertain whether antidepressants changes treatment acceptability ‐ dropouts compared with psychological interventions (very low certainty).
It is very uncertain whether antidepressants changes treatment acceptability ‐ dropouts compared with psychosocial interventions (very low certainty).
It is very uncertain whether antidepressants changes treatment acceptability ‐dropouts compared with any other pharmacological intervention (very low certainty).
The review found no eligible studies for this question.
Antidepressants showed no clear difference in treatment acceptability ‐ dropouts compared with placebo (low certainty).
Antidepressants showed no clear difference in acceptability: dropouts compared with placebo: all studies (low certainty).
Antidepressants showed no clear difference in acceptability (all‐cause drop‐outs4) compared with a combination of medications (low certainty).
The review found no eligible studies for this question.
Tricyclic antidepressants showed no clear difference in acceptability (all‐cause drop‐outs4) compared with another medication (low certainty).
New‐generation antidepressants showed no clear difference in acceptability (all‐cause drop‐outs) compared with placebo (low certainty).
Antidepressants plus benzodiazepines showed no clear difference in acceptability of treatment (dropout for any reason) compared with antidepressants alone (moderate certainty).